Morristown, NJNCT07226089Now EnrollingIRB Ready

ISS Clinical Trial in Morristown, NJ

Access cutting-edge iss treatment through this clinical trial at a research site in Morristown. Study-provided care at no cost to qualified participants.

Sponsored by Rabin Medical Center

Quick Self-Assessment

See if you qualify for this Morristown location

Preparing your pre-screening questions…

Expert Care in Morristown

Access iss specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related iss treatment provided free

Apply for This Morristown Location

Check if you qualify for this iss clinical trial in Morristown, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Morristown

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Morristown site if eligible
  4. 4Begin participation

About This ISS Study in Morristown

This study is a randomized, open-label, active controlled, parallel group study comparing the efficacy and safety of once weekly Somatrogon to daily Growth Hormone (Genotropin) in pre-pubertal children with short stature either born Small for Gestational Age (SGA) or with Idiopathic Short Stature (ISS). The planned study duration is 12 months with a screening period of up to 30 days. The study will consist of two groups: 140 children with SGA who are naïve to GH treatment will be randomized 1:1 to receive either Somatrogon or Genotropin for 12 months. A second group will include 114 children with ISS who are naïve to GH treatment who will be randomized 1:1 to receive either Somatrogon or Genotropin for 12 months.

Sponsor: Rabin Medical Center

Who Can Participate

Inclusion Criteria

Diagnosis of SGA or ISS. SGA, defined as born with a birth weight and/or length \<-2 SDS below the mean for gestational age. ISS, defined as height \< -2 SDS for age and gender without evidence of GHD
Females aged ≥3 years and \<9 years. Males aged ≥3 years and \<11 years
Pre-pubertal- Tanner stage 1 for breasts and testes.
A bone age of not more than chronological age recorded in previous 8 weeks.
Current height \< -2 SDS for age and gender.
Participants using hormonal replacement therapy(s) must be on an optimized and stable treatment regimen (hormone levels within normal ranges on screening) for at least three months prior to screening
Participants who are willing and able to comply with all scheduled visits, treatment plan, laboratory tests, and other study procedures.

Exclusion Criteria

History of cancer, radiation therapy or chemotherapy.
History of GHD.
Children who are small due to malnutrition, defined as a Z score of weight for height and/or BMI below -2 for age, according to national standards.
History of HIV-positive, acquired immune deficiency syndrome (AIDS), hepatitis B, hepatitis C, or tuberculosis.
Microcephaly (Head Circumference \< -2 SDS)
Any chronic disease or diagnosis, likely to affect growth, including but not limited to gastrointestinal disorder, celiac disease, untreated thyroid disease, diabetes mellitus and metabolic disorders.
Known or suspected skeletal dysplasias
Known or suspected chromosomal abnormalities
IGF-1 \>2 SDS
Any disorder or condition which, in the opinion of the investigator, might jeopardize participant's safety or compliance with the protocol
Prior exposure to growth promoting therapy
Current use of any prohibited concomitant medication(s): Any rhGH or growth-promoting therapy, Any therapy that affects appetite or weight, Psychiatric medications associated with weight changes and/or diabetes, excluding medications used to treat ADHD, Any androgen or estrogen therapy including over the counter supplements, Systemic corticosteroids (inhaled or oral) exceeding the doses: Inhaled: \> 400 μg/day of inhaled budesonide or equivalent. Oral: \> 8 mg/m2/day of oral hydrocortisone or equivalent.
Previous administration with an investigational drug within 90 days.
Fasting blood glucose \>126 mg/dL
Renal impairment
Hepatic dysfunction.
Known hypersensitivity to the components of the study intervention

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Morristown?

Yes, this clinical trial (NCT07226089) has an active research site in Morristown, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

ISS Treatment Options in Morristown, NJ

If you're searching for iss treatment options in Morristown, NJ, this clinical trial (NCT07226089) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Morristown research site is actively enrolling participants for this clinical trial. You'll receive care from experienced iss specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all iss clinical trials near you to find additional studies recruiting in your area.

More Sarcoma Trials in Morristown, NJ

See all sarcoma clinical trials recruiting in Morristown — not just this study.

Browse Sarcoma Trials in Morristown →

Browse More Trials by Condition

Sarcoma TrialsAortic Aneurysm TrialsRheumatic Diseases TrialsEndometriosis TrialsMarfan Syndrome TrialsEhlers-Danlos Syndrome TrialsSarcoma Soft Tissue TrialsAll Conditions →

Ready to Join in Morristown?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Morristown, NJ